Revolution Medicines (RVMD) Receives FDA’s “Safe to Proceed” Letter for Daraxonrasib

🌐 Yahoo Finance —
Revolution Medicines (RVMD) Receives FDA’s “Safe to Proceed” Letter for Daraxonrasib

AI Summary

Revolution Medicines has received a 'Safe to Proceed' letter from the FDA for its drug daraxonrasib, marking a significant step forward in the development process. This news is pivotal for the company's future and the potential treatment options for patients.

Deals Health FDA approval daraxonrasib Revolution Medicines cancer treatment

Read original source →